Healthtech Startups
17,195 companies tagged Healthtech, with their investors and founders.
0 investors
0 investors
0 investors
0 investors
0 investors
C21 Investments Inc. is a vertically-integrated cannabis company. It is publicly traded (CSE: CXXI; OTCQX: CXXIF).
0 investors
0 investors
C4 Imaging develops the SIRIUS MRI Marker, a device for precise localization of implanted LDR seeds in MRI imaging to support post-implant quality assurance in brachytherapy treatments. The product helps ensure accurate treatment delivery and protects critical anatomical structures during radiation therapy procedures.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Cadrenal Therapeutics is a clinical-stage biopharmaceutical company developing anticoagulation and antithrombotic therapies for cardiovascular and thrombotic disorders. Its pipeline includes CAD-1005, a first-in-class 12-LOX inhibitor for heparin-induced thrombocytopenia, tecarfarin for end-stage kidney disease and LVAD patients, and frunexian, an intravenous Factor XIa inhibitor for acute/critical care settings.</parameter> <parameter name="founders">[]
0 investors
0 investors
CAIPA Foundation is a not-for-profit funded mainly by physician members of the Chinese-American IPA that runs community service and health awareness programs for Asian American communities through education, advocacy, and access to culturally and linguistically tailored medical services. It offers assistance under the Medicaid 1115 Waiver Program, connecting eligible members in the Greater New York area to food, housing, and community resources in Mandarin, Cantonese, and English.
0 investors
Caira Surgical develops joint replacement software, 3D scanning, and radar-based tracking technologies for orthopedic surgeons, with its first product being a navigation system for knee replacement. Its products are still in development and not yet marketed or registered.
0 investors
Cairn Therapeutics is a biopharmaceutical company developing oncology treatments intended to address drawbacks of standard chemotherapy such as side effects, low potency, and multidrug resistance. Its lead candidate, CT-262, is based on duocarmycin drug chemistry invented by Dale Boger at Scripps Research.
0 investors
0 investors
Caliber I.D. (Caliber Imaging & Diagnostics) develops medical imaging products, including the VivaScope, VivaNet, VivaCam and VivaScan lines, for diagnostic use.
0 investors
0 investors
0 investors
Calidar develops X-ray diffraction imaging technology, including a patented 4D Mammography system that noninvasively maps X-ray scatter signatures in breast tissue to detect molecular-level markers of cancer. The technology aims to provide earlier and more accurate breast cancer diagnosis without biopsies, needles, or contrast injection.
0 investors
Calidi is a biotech company developing genetic medicine therapies. The page describes it as a biotech startup working in the genetic medicine field.
0 investors